Are you working on these ATMP's or clearing a path to continuous biologics manufacturing? ISPE invites you to submit a proposal for our 2018 ISPE Biopharmaceutical Manufacturing Conference , December 10-12, Huntington Beach, CA
The 2018 ISPE Biopharmaceutical Manufacturing Conference focuses on the quickly evolving science of biologics manufacturing for new modalities, and the novel technologies that leverage existing capacity and move us towards continuous manufacturing. Share your expertise and help your peers prepare to manufacture these novel medicines and deliver on our promise of supplying life changing medicines to patients across the globe.
The call for proposals is open until May 30, 2018.
Clinical to Product Launch
Has your firm successfully navigated the journey from clinical to commercial? Share your story with a highly engaged Biopharms audience.
Regulatory/CMC/GMP/QA/Validation
How has your company’s quality processes evolved along with evolving Biopharmaceutical technologies, therapies and personal medicine?
Cost
Have you unlocked the challenge of efficient and sustainable manufacturing for new modalities? What Lean and Manufacturing Excellence processes have you implemented related to cost?
Facilities, Equipment, and Processes
Reduced scale, multiple concurrent batches, unique and stringent contamination challenges – do you have a success story of how your firm safely and reliably houses processes for new treatments?
Supply Chain
Future state of biomanufacturing requires new and higher levels of supply chain logistics and control. Personalized medicine presents unique chain of custody and logisitics challenges. Share your success in a compelling case study.
I speak for all the conference committee volunteers when I say we look forward to reading your proposals and learning how you are propelling the industry forward.
Andre Walker, BSChEng, CPIP, is a consultant with 40 years of experience providing technical and quality support for manufacturers of biopharmaceuticals, medical devices, and consumer...
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has recently announced the adoption of the revised guideline
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.